1887

Abstract

Human parainfluenza virus type 3 (PIV-3) is one of the leading causes of paediatric viral respiratory disease. The PIV-3 genome encodes two envelope glycoproteins, F and HN, which are the major targets for the host antibody response. We have expressed secreted forms of the F and HN proteins and a novel chimeric FHN glycoprotein in insect cells using recombinant baculovirus vectors and secreted forms of the F and FHN glycoproteins in stably transformed Chinese hamster ovary (CHO) cells. Comparison of the mammalian cell- and insect cell-expressed F and FHN proteins by SDS-PAGE showed that the CHO cell-expressed proteins are several kilodaltons larger in size than the baculovirus-produced proteins. A partial characterization of the oligosaccharide structures of the F and FHN proteins revealed that the size difference is due to the different oligosaccharide structures added to these proteins by the two cell lines. The F, HN and FHN proteins were immunoaffinity-purified from the culture medium of baculovirus-infected Sf9 cells and the F and FHN proteins were immunoaffinity-purified from the culture medium of CHO cells. A comparison of the immunogenicity and efficacy of the mammalian cell- and insect cell-produced FHN proteins was tested in cotton rats. The CHO cell- and baculovirus-produced FHN proteins were found to induce similar levels of PIV-3-specific ELISA-positive and neutralizing antibodies and both proteins provided near complete protection when animals were vaccinated with low doses of the FHN protein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-3-459
1993-03-01
2022-10-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/3/JV0740030459.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-3-459&mimeType=html&fmt=ahah

References

  1. Aeed P. A., Guido D. M., Mathews W. R., Elhammer A. P. 1992; Characterization of the A-glycans on recombinant human renin synthesized by Chinese hamster ovary cells. II. Sequential exoglycosidase digestion and chemical analysis. Biochemistry 31:6951–6961
    [Google Scholar]
  2. Brideau R. J., Walters R. R., Stier M. A., Wathen M. W. 1989; Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. Journal of General Virology 70:2637–2644
    [Google Scholar]
  3. Brideau R. J., Oien N. L., Lehman D. J., Homa F. L., Wathen M. W. 1993; Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein. Journal of General Virology 74:471–477
    [Google Scholar]
  4. Butters T. D., Hughes R. C. 1981; Isolation and characterization of mosquito cell membrane glycoproteins. Biochimica et biophysica acta 640:655–671
    [Google Scholar]
  5. Carlson D. M. 1968; Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. Journal of Biological Chemistry 243:616–626
    [Google Scholar]
  6. Chanock R. M., McIntosh K. 1990; Parainfluenza viruses. In Virology, 2nd edn. pp. 963–987 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  7. Choppin P. W., Scheid A. 1980; The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Reviews of Infectious Diseases 2:40–61
    [Google Scholar]
  8. Collins P. L., Mottet G. 1991; Homooligomerization of the hemagglutin-inneuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity. Journal of Virology 65:2362–2371
    [Google Scholar]
  9. Cummings R. D., Kornfeld S., Schneider W. J., Hogood K. K., Tolleshaug H., Brown M. S., Goldstein J. L. 1983; Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor. Journal of Biological Chemistry 258:5261–5273
    [Google Scholar]
  10. Elango N., Coligan J. E., Jambou R. C., Venkatesan S. 1986; Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein : nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. Journal of Virology 57:481–489
    [Google Scholar]
  11. Greenfield C., Patel G., Clark S., Jones N., Waterfield M. D. 1988; Expression of the human EGF receptor with ligand stimulatable kinase activity in insect cells using a baculovirus vector. EM BO Journal 7:139–146
    [Google Scholar]
  12. Hall S. L., Murphy B. R., van Wyke Coelingh K. L. 1991; Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus. Vaccine 9:659–667
    [Google Scholar]
  13. Henrickson K. J., Kingsbury D. W., van Wyke Coelingh K. L., Naeve C. W., Portner A. 1991; Neutralizing epitopes of human parainfluenza virus type 3 are conformational and cannot be imitated by synthetic peptides. Vaccine 9:243–249
    [Google Scholar]
  14. Homa F. L., Otal T. M., Glorioso J. C., Levine M. 1986; Transcription control signals of a herpes simplex virus type 1 late gene lie within bases - 34 to +124 relative to the 5′ terminus of the mRNA. Molecular and Cellular Biology 6:3652–3666
    [Google Scholar]
  15. Hsieh P., Robbins P. W. 1984; Regulation of asparagine-linked oligosaccharide processing. Oligosaccharide processing in Aedes albopictus mosquito cells. Journal of Biological Chemistry 259:2375–2382
    [Google Scholar]
  16. Kasel J. A., Frank A. L., Keitel W. A., Taber L. H., Glezen W. P. 1984; Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children. Journal of Virology 52:828–832
    [Google Scholar]
  17. Kuroda K., Geyer H., Geyer R., Doerfler W., Klenk H.-D. 1990; The oligosaccharides of influenza hemagglutinin expressed in insect cells by a baculovirus vector. Virology 174:418–429
    [Google Scholar]
  18. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  19. Merz D. C., Scheid A., Choppin P. W. 1980; Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention and spread of infection. Journal of Experimental Medicine 151:275–288
    [Google Scholar]
  20. Moore J. P., McKeating J. A., Jones I. M., Stephens P. E., Clements G., Thomson S., Weiss R. A. 1990; Characterization of recombinant gpl20 and gpl60 from HIV-1: binding to monoclonal antibodies and soluble CD4. AIDS 4:307–315
    [Google Scholar]
  21. Morrissey J. H. 1981; Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Analytical Biochemistry 117:307–310
    [Google Scholar]
  22. Parks G. D., Lamb R. A. 1990; Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein. Virology 178:498–508
    [Google Scholar]
  23. Ray R., Glaze B. J., Compans R. W. 1988; Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. Journal of Virology 62:783–787
    [Google Scholar]
  24. Ray R., Galinski M. S., Compans R. W. 1989; Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property. Virus Research 12:169–180
    [Google Scholar]
  25. Scheid A., Choppin P. W. 1974; Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475–490
    [Google Scholar]
  26. Scheid A., Choppin P. W. 1977; Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80:54–66
    [Google Scholar]
  27. Scheid A., Caligiuri L. A., Compans R. W., Choppin P. W. 1972; Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 50:640–652
    [Google Scholar]
  28. Spriggs M. K., Collins P. L. 1991; Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein. Journal of Cell Biology 111:31–44
    [Google Scholar]
  29. Spriggs M. K., Olmsted R. A., Venkatesan S., Coligan J. E., Collins P. L. 1986; Fusion glycoprotein of human parainfluenza virus type 3 : nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses. Virology 152:241–251
    [Google Scholar]
  30. Spriggs M. K., Murphy B. R., Prince G. A., Olmsted R. A., Collins P. L. 1987; Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses : contributions of the individual proteins to host immunity. Journal of Virology 61:3416–3423
    [Google Scholar]
  31. Summers M. D., Smith G. E. 1987 A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. College Station: Texas Agricultural Experiment Station;
    [Google Scholar]
  32. van Wyke Coelingh K. L., Winter C. C. 1990; Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites. Journal of Virology 64:1329–1334
    [Google Scholar]
  33. van Wyke Coelingh K. L., Murphy B. R., Collins P. L., Lebacq-Verheyden A.-M., Battey J. F. 1981; Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus. Virology 160:465–172
    [Google Scholar]
  34. van Wyke Coelingh K. L., Winter C. C., Murphy B. R. 1983; Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957-1983. Virology 162:137–143
    [Google Scholar]
  35. Wathen M. W., Brideau R. J., Thomsen D. R., Murphy B. R. 1989; Characterization of a novel human respiratory syncytial virus chimeric FG glycoprotein expressed using a baculovirus vector. Journal of General Virology 70:2625–2635
    [Google Scholar]
  36. Wathen M. W., Aeed P. A., Elhammer A. P. 1991; Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9. Biochemistry 30:2863–2868
    [Google Scholar]
  37. Weber A., Märtz L., Altmann F. 1986; Characteristics of the asparagine-linked oligosaccharide from honey-bee venom phospholipase A2. Evidence for the presence of terminal N-acetylglucosamine and fucose in an insect glycoprotein. Comparative Biochemistry and Physiology 83B:321–324
    [Google Scholar]
  38. Weber A., Schroder H., Thalberg K., Märtz L. 1987; Specific interaction of IgE antibodies with a carbohydrate epitope of honey bee venom phospholipase Aa. Allergy 42:464–470
    [Google Scholar]
  39. Wirth M., Bode J., Zettlmeissl G., Hauser H. 1988; Isolation of overproducing recombinant cell lines by a fast and simple selection procedure. Gene 73:419–426
    [Google Scholar]
  40. Wojchowski D. M., Orkin S. H., Sytkowski A. J. 1987; Active human erythropoietin expressed in insect cells using a baculovirus vector: a role for A-linked oligosaccharide. Biochimica et biophysica acta 910:224–232
    [Google Scholar]
  41. Zettlmeissl G., Wirth M., Hauser H., Kupper H. A. 1988; Efficient expression system for human antithrombin III in baby hamster kidney cells. Behring Institute Mitteilungen 82:26–34
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-3-459
Loading
/content/journal/jgv/10.1099/0022-1317-74-3-459
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error